Immunization, measles second dose in High income
High income: Immunization, measles second dose was 91.1% in 2024. ▲ Rising
Immunization, measles second dose in High income, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
High income recorded 91.1% for immunization, measles second dose in 2024.
The figure is up 0.2% on the previous year and down 0.1% over ten years.
Over the whole period, immunization, measles second dose in High income peaked at 92.8% in 2019 and was at its lowest, 46.4%, in 2000.
That places High income 7th out of 43 groups with data for 2024, putting it in the top quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, measles second dose in High income, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 46.4% | — |
| 2001 | 52.6% | +13.3% |
| 2002 | 60.2% | +14.5% |
| 2003 | 61.2% | +1.5% |
| 2004 | 67.7% | +10.7% |
| 2005 | 68.5% | +1.2% |
| 2006 | 69.7% | +1.7% |
| 2007 | 70.5% | +1.2% |
| 2008 | 77.0% | +9.2% |
| 2009 | 78.5% | +2.0% |
| 2010 | 82.9% | +5.6% |
| 2011 | 83.4% | +0.6% |
| 2012 | 86.2% | +3.4% |
| 2013 | 90.0% | +4.5% |
| 2014 | 91.3% | +1.4% |
| 2015 | 91.6% | +0.3% |
| 2016 | 92.1% | +0.5% |
| 2017 | 92.4% | +0.3% |
| 2018 | 92.6% | +0.2% |
| 2019 | 92.8% | +0.3% |
| 2020 | 92.3% | -0.6% |
| 2021 | 92.3% | -0.0% |
| 2022 | 92.0% | -0.3% |
| 2023 | 90.9% | -1.1% |
| 2024 | 91.1% | +0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 65.2% | 46.4% | 78.5% | 10 |
| 2010s | 89.5% | 82.9% | 92.8% | 10 |
| 2020s | 91.7% | 90.9% | 92.3% | 5 |
More health data for High income
- Population ages 35-39, female, annual growth rate -0.0602 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0338 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate -0.0702 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0367 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 0.4572 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0337 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, per capita 0.0322 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in High income?
- Immunization, measles second dose in High income was 91.1% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in High income?
- The highest recorded value was 92.8% in 2019.
- What is the lowest immunization, measles second dose recorded in High income?
- The lowest recorded value was 46.4% in 2000.
- How does High income rank for immunization, measles second dose?
- High income ranks 7th out of 43 groups with data for 2024.
- Is immunization, measles second dose rising or falling in High income?
- Over the last ten years it is down 0.1%. The long-run trend across the full record is rising.
- Where does this High income data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.